Rapid clinical improvement of amyloid A amyloidosis following treatment with tocilizumab despite persisting amyloid deposition: a case report.

about

Rapid clinical improvement of amyloid A amyloidosis following treatment with tocilizumab despite persisting amyloid deposition: a case report.

Item

http://www.wikidata.org/entity/Q47244728

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Rapid clinical improvement of ...... oid deposition: a case report.

@en

Rapid clinical improvement of ...... oid deposition: a case report.

@nl

type

Item

label

Rapid clinical improvement of ...... oid deposition: a case report.

@en

Rapid clinical improvement of ...... oid deposition: a case report.

@nl

prefLabel

Rapid clinical improvement of ...... oid deposition: a case report.

@en

Rapid clinical improvement of ...... oid deposition: a case report.

@nl

P1476

Rapid clinical improvement of ...... loid deposition: a case report

@en

P2093

Hiroo Kumagai

http://www.w3.org/2001/XMLSchema#string

Kazue Nagai

http://www.w3.org/2001/XMLSchema#string

Naoki Oshima

http://www.w3.org/2001/XMLSchema#string

Takahiro Uchida

http://www.w3.org/2001/XMLSchema#string

Takashi Nakanishi

http://www.w3.org/2001/XMLSchema#string

Toshihiko Imakiire

http://www.w3.org/2001/XMLSchema#string

Yuji Yamada

http://www.w3.org/2001/XMLSchema#string

P2860

Renal cell carcinoma presenting as AA amyloidosis: a case report and review of the literature

Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview.

Amyloid A amyloidosis secondary to rheumatoid arthritis: pathophysiology and treatments.

Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.

Renal cell carcinoma and systemic amyloidosis: demonstration of AA protein and review of the literature.

The systemic amyloidoses.

Amyloidosis: a review of recent diagnostic and therapeutic developments.

Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis.

Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis.

Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.

P2888

s12882-017-0799-8

P304

377

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1186/S12882-017-0799-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Akira Yamagata

P577

2017-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100108884

http://www.w3.org/2001/XMLSchema#string

P698

29287589

http://www.w3.org/2001/XMLSchema#string

P932

5747944

http://www.w3.org/2001/XMLSchema#string